RNA targeting unleashes indiscriminate nuclease activity of CRISPR-Cas12a2.
Jack P K BravoThomson HallmarkBronson NaegleChase L BeiselRyan N JacksonDavid W TaylorPublished in: Nature (2023)
Cas12a2 is a CRISPR-associated nuclease that performs RNA-guided, sequence-nonspecific degradation of single-stranded RNA, single-stranded DNA and double-stranded DNA following recognition of a complementary RNA target, culminating in abortive infection 1 . Here we report structures of Cas12a2 in binary, ternary and quaternary complexes to reveal a complete activation pathway. Our structures reveal that Cas12a2 is autoinhibited until binding a cognate RNA target, which exposes the RuvC active site within a large, positively charged cleft. Double-stranded DNA substrates are captured through duplex distortion and local melting, stabilized by pairs of 'aromatic clamp' residues that are crucial for double-stranded DNA degradation and in vivo immune system function. Our work provides a structural basis for this mechanism of abortive infection to achieve population-level immunity, which can be leveraged to create rational mutants that degrade a spectrum of collateral substrates.
Keyphrases
- nucleic acid
- crispr cas
- genome editing
- binding protein
- circulating tumor
- cell free
- single molecule
- high resolution
- genome wide
- structural basis
- single cell
- dna binding
- mass spectrometry
- gold nanoparticles
- heat shock
- gene expression
- dna methylation
- oxidative stress
- amino acid
- cancer therapy
- circulating tumor cells
- reduced graphene oxide